Brett Deml1,2, Linda M Reis1, Sanaa Muheisen1, David Bick1, Elena V Semina1,2. 1. Department of Pediatrics and Children's Research Institute at the Medical College of Wisconsin and Children's Hospital of Wisconsin, Milwaukee, Wisconsin. 2. Department of Cell Biology, Neurobiology, and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin.
Abstract
BACKGROUND: Congenital microphthalmia and coloboma are severe developmental defects that are frequently associated with additional systemic anomalies and display a high level of genetic heterogeneity. METHODS: To identify the pathogenic variant in a patient with microphthalmia, coloboma, retinal dystrophy, microcephaly, and other features, whole exome sequencing analysis of the patient and parental samples was undertaken. To further explore the identified variant/gene, expression and functional studies in zebrafish were performed. RESULTS: Whole exome sequencing revealed a de novo variant, c.473_474delGA, p.(Arg158Lysfs*4), in EFTUD2 which encodes a component of the spliceosome complex. Dominant mutations in EFTUD2 cause Mandibulofacial Dysostosis, Guion-Almeida type, which does not involve microphthalmia, coloboma, or retinal dystrophy; analysis of genes known to cause these ocular phenotypes identified several variants of unknown significance but no causal alleles in the affected patient. Zebrafish eftud2 demonstrated high sequence conservation with the human gene and broad embryonic expression. TALEN-mediated disruption was employed to generate a c.378_385 del, p.(Ser127Aspfs*23) truncation mutation in eftud2. Homozygous mutants displayed a reduced head size, small eye, curved body, and early embryonic lethality. Apoptosis assays demonstrated a striking increase in terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling (TUNEL)-positive cells in the developing brain, eye, spinal cord, and other tissues starting at 30 hours postfertilization. CONCLUSION: This study reports a novel mutation in EFTUD2 in a Mandibulofacial Dysostosis, Guion-Almeida type patient with unusual ocular features and the generation of a first animal model of eftud2 deficiency. The severe embryonic phenotype observed in eftud2 mutants indicates an important conserved role during development of diverse tissues in vertebrates.
BACKGROUND:Congenital microphthalmia and coloboma are severe developmental defects that are frequently associated with additional systemic anomalies and display a high level of genetic heterogeneity. METHODS: To identify the pathogenic variant in a patient with microphthalmia, coloboma, retinal dystrophy, microcephaly, and other features, whole exome sequencing analysis of the patient and parental samples was undertaken. To further explore the identified variant/gene, expression and functional studies in zebrafish were performed. RESULTS: Whole exome sequencing revealed a de novo variant, c.473_474delGA, p.(Arg158Lysfs*4), in EFTUD2 which encodes a component of the spliceosome complex. Dominant mutations in EFTUD2 cause Mandibulofacial Dysostosis, Guion-Almeida type, which does not involve microphthalmia, coloboma, or retinal dystrophy; analysis of genes known to cause these ocular phenotypes identified several variants of unknown significance but no causal alleles in the affected patient. Zebrafisheftud2 demonstrated high sequence conservation with the human gene and broad embryonic expression. TALEN-mediated disruption was employed to generate a c.378_385 del, p.(Ser127Aspfs*23) truncation mutation in eftud2. Homozygous mutants displayed a reduced head size, small eye, curved body, and early embryonic lethality. Apoptosis assays demonstrated a striking increase in terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling (TUNEL)-positive cells in the developing brain, eye, spinal cord, and other tissues starting at 30 hours postfertilization. CONCLUSION: This study reports a novel mutation in EFTUD2 in a Mandibulofacial Dysostosis, Guion-Almeida type patient with unusual ocular features and the generation of a first animal model of eftud2 deficiency. The severe embryonic phenotype observed in eftud2 mutants indicates an important conserved role during development of diverse tissues in vertebrates.
Authors: Fatema Zahrani; Mohammed A Aldahmesh; Muneera J Alshammari; Selwa A F Al-Hazzaa; Fowzan S Alkuraya Journal: Am J Hum Genet Date: 2013-02-28 Impact factor: 11.025
Authors: Daniela V Luquetti; Anne V Hing; Mark J Rieder; Deborah A Nickerson; Emily H Turner; Joshua Smith; Sarah Park; Michael L Cunningham Journal: Am J Med Genet A Date: 2012-12-14 Impact factor: 2.802
Authors: Linda M Reis; Rebecca C Tyler; Sanaa Muheisen; Victor Raggio; Leonardo Salviati; Dennis P Han; Deborah Costakos; Hagith Yonath; Sarah Hall; Patricia Power; Elena V Semina Journal: Hum Genet Date: 2013-03-19 Impact factor: 4.132
Authors: M Chiara Manzini; Dimira E Tambunan; R Sean Hill; Tim W Yu; Thomas M Maynard; Erin L Heinzen; Kevin V Shianna; Christine R Stevens; Jennifer N Partlow; Brenda J Barry; Jacqueline Rodriguez; Vandana A Gupta; Abdel-Karim Al-Qudah; Wafaa M Eyaid; Jan M Friedman; Mustafa A Salih; Robin Clark; Isabella Moroni; Marina Mora; Alan H Beggs; Stacey B Gabriel; Christopher A Walsh Journal: Am J Hum Genet Date: 2012-09-07 Impact factor: 11.025
Authors: Håvard Aanes; Olga Østrup; Ingrid S Andersen; Lars F Moen; Sinnakaruppan Mathavan; Philippe Collas; Peter Alestrom Journal: BMC Genomics Date: 2013-05-15 Impact factor: 3.969
Authors: Katherine A Wood; Charlie F Rowlands; Wasay Mohiuddin Shaikh Qureshi; Huw B Thomas; Weronika A Buczek; Tracy A Briggs; Simon J Hubbard; Kathryn E Hentges; William G Newman; Raymond T O'Keefe Journal: Hum Mol Genet Date: 2019-11-15 Impact factor: 6.150
Authors: Marie-Claude Beauchamp; Anissa Djedid; Eric Bareke; Fjodor Merkuri; Rachel Aber; Annie S Tam; Matthew A Lines; Kym M Boycott; Peter C Stirling; Jennifer L Fish; Jacek Majewski; Loydie A Jerome-Majewska Journal: Hum Mol Genet Date: 2021-05-28 Impact factor: 6.150
Authors: Katherine A Wood; Charlie F Rowlands; Huw B Thomas; Steven Woods; Julieta O'Flaherty; Sofia Douzgou; Susan J Kimber; William G Newman; Raymond T O'Keefe Journal: PLoS One Date: 2020-07-31 Impact factor: 3.240